Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition

Published:2015-10 Issue:2 Volume:129 Page:101-106
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Guo Wenjie,Hu Shasha,Elgehama Ahmed,Shao Fenli,Ren Ren,Liu Wen,Zhang Wenjing,Wang Xinlei,Tan Renxiang,Xu Qiang,Sun Yang,Jiao Ruihua

Funder

Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference28 articles.

1. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England;Stone;Eur J Gastroenterol Hepatol,2003

2. Inflammation and colon cancer;Terzic;Gastroenterology,2010

3. The immunological and genetic basis of inflammatory bowel disease;Bouma;Nat Rev Immunol,2003

4. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models;Nell;Nat Rev Micro,2010

5. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases;Strober;Gastroenterology,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biosynthetic logic and enzymatic machinery of approved fungi-derived pharmaceuticals and agricultural biopesticides;Natural Product Reports;2024

2. Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway;BMC Complementary Medicine and Therapies;2023-08-16

3. Mechanism of inflammasomes in cancer and targeted therapies;Frontiers in Oncology;2023-03-20

4. Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study;World Journal of Gastroenterology;2023-02-14

5. NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease;Therapeutic Advances in Gastroenterology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3